Cargando…
Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma
Drug resistance to anti-cancer agents is a major concern regarding the successful treatment of malignant tumors. Recent studies have suggested that acquired resistance to anti-epidermal growth factor receptor (EGFR) therapies such as cetuximab are in part caused by genetic alterations in patients wi...
Autores principales: | Uzawa, Katsuhiro, Amelio, Antonio L., Kasamatsu, Atsushi, Saito, Tomoaki, Kita, Akihiro, Fukamachi, Megumi, Sawai, Yuki, Toeda, Yuriko, Eizuka, Keitaro, Hayashi, Fumihiko, Kato-Kase, Ikuko, Sunohara, Masataka, Iyoda, Manabu, Koike, Kazuyuki, Nakashima, Dai, Ogawara, Katsunori, Endo-Sakamoto, Yosuke, Shiiba, Masashi, Takiguchi, Yuichi, Yamauchi, Mitsuo, Tanzawa, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704133/ https://www.ncbi.nlm.nih.gov/pubmed/31434965 http://dx.doi.org/10.1038/s41598-019-48717-w |
Ejemplares similares
-
Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression
por: Kase, Yutaro, et al.
Publicado: (2021) -
Epithelial Cell Transforming Sequence 2 in Human Oral Cancer
por: Iyoda, Manabu, et al.
Publicado: (2010) -
Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells
por: Uzawa, Katsuhiro, et al.
Publicado: (2013) -
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis
por: Saito, Tomoaki, et al.
Publicado: (2015) -
SYT12 plays a critical role in oral cancer and may be a novel therapeutic target
por: Eizuka, Keitaro, et al.
Publicado: (2019)